WO2012059798A2 - NOVEL METHOD FOR RACEMIZATION OF OPTICALLY PURE β-CYANO ESTER TO CORRESPONDING RACEMIC β-CYANO ACID - Google Patents

NOVEL METHOD FOR RACEMIZATION OF OPTICALLY PURE β-CYANO ESTER TO CORRESPONDING RACEMIC β-CYANO ACID Download PDF

Info

Publication number
WO2012059798A2
WO2012059798A2 PCT/IB2011/000485 IB2011000485W WO2012059798A2 WO 2012059798 A2 WO2012059798 A2 WO 2012059798A2 IB 2011000485 W IB2011000485 W IB 2011000485W WO 2012059798 A2 WO2012059798 A2 WO 2012059798A2
Authority
WO
WIPO (PCT)
Prior art keywords
cyano
ethanol
methyl
doped
vii
Prior art date
Application number
PCT/IB2011/000485
Other languages
French (fr)
Other versions
WO2012059798A3 (en
Inventor
Bhairab Nath Roy
Girij Pal Singh
Piyush Suresh Lathi
Manoj Kunjabihari Agrawal
Rangan Mitra
Manoj Dattatraya Rupnawar
Original Assignee
Lupin Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Limited filed Critical Lupin Limited
Publication of WO2012059798A2 publication Critical patent/WO2012059798A2/en
Publication of WO2012059798A3 publication Critical patent/WO2012059798A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups

Definitions

  • This invention relates to process for racemization of ( ?)-3-cyano-5-methyl hexanoic acid ethyl ester (VII) in presence of a base to obtain directly (&S)-3-cyano-5-methyl hexanoic acid (III).
  • This invention provides a method for racemization of optically active ⁇ - cyano ester directly to corresponding racemic ⁇ - cyano acid.
  • this invention provides a novel, highly cost effective, operation friendly, "green” process for racemization of (R) - 3-cyano-5-methyl-hexanoic acid ethyl ester (VII) to .
  • the object of the present invention is to provide a process for recycling of ( ?)-3-cyano-5- methyl-hexanoic acid (V) via converting into corresponding ester i.e. (i?)-3-cyano-5-methyl- hexanoic acid ethyl ester (VII), followed by racemization to obtain (RS) - 3-cyano-5-methyl- hexanoic acid (III), which could be reused for resolution through diastereomeric salt formation with cinchonidine, thereby improving the atom economy and hence further reduce the cost for the synthesis of (S)-pregabalin.
  • the present invention is directed towards racemization of (ft)-3-cyano-5 -methyl hexanoic acid ethyl ester (VII) to (i?S)-3-cyano-5-methyl hexanoic acid (III) with a base, which is directly utilized for resolution with cinchonidine as mentioned hereinbefore.
  • the invention is summarized below in scheme C.
  • the substrates reported in literature and mentioned above contain only one electron withdrawing group i.e. nitrile, hence, when above said substrates were subjected to racemization in presence of catalytic amount of base, proton which is attached to carbon bearing optically active center i.e. "Ha”, which is a to cyano functionality only gets abstracted, which results into isomerization of said nitrile substrates.
  • Retention time for (R) -3-cyano-5-methylhexanoic acid ethyl ester (VII) is 30.10 min and for (S) -3-cyano-5-methylhexanoic acid ethyl ester (II) is 31.09 min.
  • Product was also characterized by NMR and IR having the following spectral data.
  • racemization of (R) -3-cyano-5-methylhexanoic acid (V) to (RS) -3-cyano-5- methylhexanoic acid (III) comprised of the following steps: compound (V) was converted into corresponding ester i.e. compound (VII) through esterification reaction such as "mixed-anhydride” technique employing ethylchloroformate/ triethylamine with ethanol or through Steglich Esterification or acid catalyzed esterification or esterification by any other conventional methods.
  • compound (VII) was racemized to obtain compound (III) in presence of alkali metal alkoxides in a mixture of organic solvent e.g. methyl tert-butyl ether doped with 2% ethanol, dimethyl sulfoxide doped with 2% ethanol, dimethylformamide doped with 2% ethanol, dimethoxyethane doped with 2% ethanol, 2-methyl tetrahydrofuran doped with 2% ethanol and N-Methyl-2-pyrrolidone doped with 2% ethanol.
  • organic solvent e.g. methyl tert-butyl ether doped with 2% ethanol, dimethyl sulfoxide doped with 2% ethanol, dimethylformamide doped with 2% ethanol, dimethoxyethane doped with 2% ethanol, 2-methyl tetrahydrofuran doped with 2% ethanol and N-Methyl-2-pyrrolidone doped with 2% ethanol.
  • Alkali metal alkoxides used such as sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide, lithium methoxide, lithium ethoxide, potassium tert- butoxide preferably sodium methoxide, sodium ethoxide; more preferably sodium ethoxide.
  • Aprotic solvent used such as dimethyl sulfoxide, dimethylformamide, dimethoxyethane, 2-methyl tetrahydrofuran, methyl tert-butyl ether and N-Me ' thyl-2- ⁇ pyrrolidone preferably dimethyl sulfoxide and methyl tert-butyl ether.
  • Protic solvent used such as methanol, ethanol, propanol and butanol, preferably ethanol. Ratio of aprotic solvent to protic solvent varied from 1:99 to 99:1, preferably ratio used was 99: 1. The quantity of base used was 1.25 mol/per mole of substrate. l) 2 % Ethanol
  • the enantiomeric excess (ee) for (S) - 3-cyano-5-methyl-hexanoic acid ethyl ester is determined by Gas-Liquid chromatography using a Shimadzu GC 2010 system equipped with a chiral column (Chiraledex (20m x 0.25mm x 0.12mm)), and FID detector.
  • the enantiomeric excess (ee) for (S) or (R) - 3-cyano-5-methyl-hexanoic acid is determined via converting into corresponding ester and analyzed on Gas-Liquid chromatography using a Shimadzu GC 2010 system equipped with a chiral column (Chiraledex (20m x 0.25mm x 0.12mm)), and FID detector.
  • NMR spectra are obtained at 200 and 400 MHz Bruker instruments, with CDC1 3 as solvent unless otherwise stated. Chemical shifts (3) are given in ppm relative to tetramethylsilane ( ⁇ - 0 ppm). IR spectra are recorded on Perkin Elmer Spectrum (Model: Spectrum 100) and absorption bands are given in cm '1 . Mass analyses are performed on Shimadzu LCMS 201 OA instrument.
  • Example 1 Synthesis of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) through Steglich Esterification.
  • a reactor equipped with overheard stirring is charged with 50 mL of dichloromethane 50 mL, ethanol (1.24 g), (R) - 3-cyano-5-methylhexanoic acid (2.1 g) and DCC (5.58 g) at 0 °C. The mixture is stirred for 1 h at 0 °C. Further it is stirred for 12 h at 25 °C. The extent of reaction is monitored on GC for chiral purity for (R) 3-cyano-5-methylhexanoic acid ethyl ester (1.8 g).
  • Example 2 Synthesis of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) through mixed-anhydride.
  • a reactor equipped with overheard stirring is charged with 100 mL of dichloromethane, (R) - 3- cyano-5-methylhexanoic acid (26.2 g) and triethyl amine (34.1 g) and resulting reaction mixture was cooled to 0 °C.
  • a solution of ethyl chloroformate (27.5 g) in dichloromethane (l OOmL) was slowly added to the above reaction mixture over a period of 30 min at 0°C and stirred further for 3 h at 25 °C.
  • reaction mixture was cooled to 0°C and ethanol (15.5 g) was added slowly over period of 20-25 min and resultant reaction mixture was further stirred for 1 h at 25 °C.
  • the reaction was quenched by adding 100 ml water and organic layer was separated. Aqueous layer was further extracted with dichloromethane (2*100ml).Combined organic layer was dried over sodium sulfate and solvent was evaporated under reduced pressure to obtain (R) 3-cyano-5- methylhexanoic acid ethyl ester (30.1 g) as yellow oil.
  • Example 3 Synthesis of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) in presence of sulfuric acid.
  • a reactor equipped with overheard stirring is charged with ethanol (100 mL), (R) - 3-cyano-5- methylhexanoic acid (25.0 g) and concentrated sulfuric acid (0.25 g) and resulting reaction mixture was refluxed for 6 h. After which reaction was cooled to 25 °C, solvent was evaporated under reduced pressure to obtain crude (R) - 3 -cyano-5 -methylhexanoic acid ethyl ester.
  • Example 4 Racemization of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) to (RS) 3- cyano-5-methylhexanoic acid (III) in dimethyl sulfoxide and 2 % ethanol.
  • Example 6 Racemization of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) to (RS) 3- cyano-5-methyIhexanoic acid (III) in dimethyl formamide and 2 % ethanol
  • Example 8 Racemization of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) to (RS) 3- cyano-5-methylhexanoic acid (III) in methyl-i'eri'-butyl ether
  • a reactor equipped with overheard stirring is charged with (R) 3-cyano-5 methylhexanoic acid ethyl ester (3.0 g), dimethoxy ethane (30 ml), ethanol (0.6 mL ) and sodium ethoxide (1.4 g) and resulting reaction mixture was stirred for 4 h at 75 °C.
  • reaction mixture was cooled to room temperature neutralized with acetic acid and treated with water (200 mL) in small portions to maintain the temperature below 40 °C.
  • Organic layer was separated and aqueous phase was extracted with methyl tert-butyl ether (100 mL), organic phases were combined and dried over sodium sulfate and solvent was evaporated under reduced pressure to give (RS) - 3- cyano-5 -methylhexanoic acid (2.2 g, analyzed chiral GC by converting in to ethyl ester) brown color oil.
  • Example 9 Racemization of enantiomerically enriched (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) to (RS) 3-cyano-5-methylhexanoic acid (III) in 2-methyl tetrahydrofuran

Abstract

A novel process for racemization of (R)-3-cyano-5 -methyl hexanoic acid ethyl ester directly to (RS)-3-cyano-5 -methyl hexanoic acid has been developed through a base catalyzed mechanism in a specific solvent system.

Description

NOVEL METHOD FOR RACEMIZATION OF OPTICALLY PURE β-CYANO
ESTER TO CORRESPONDING RACEMIC B-CYANO ACID
Field of the Invention:
This invention relates to process for racemization of ( ?)-3-cyano-5-methyl hexanoic acid ethyl ester (VII) in presence of a base to obtain directly (&S)-3-cyano-5-methyl hexanoic acid (III).
Background of the Invention:
The PCT application number PCT/IN2010/000440 dated 28 June 2010 entitled "Improved synthesis of optically pure (S) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (S)-pregabalin" of the present applicant reports the lipase catalyzed kinetic resolution of (RS) - 3-cyano-5-methyl-hexanoic acid ethyl ester (I) to obtain (S)- 3-cyano-5-methyl- hexanoic acid ethyl ester (II) , which was further converted to (S)-pregabalin (VI)· In the copending Indian patent Application No. 1235/KOL/2010 dated November 4, 2010, entitled "Novel, cost effective, green and industrial process for synthesis of (5)-pregabalin" of the present applicant, the inventors demonstrated the process for resolution of (RS) - 3-cyano-5- methyl-hexanoic acid (III) with cinchonidine through diastereomeric salt formation to obtain (S) - 3 -cyano-5 -methyl-hexanoic acid (IV), which was also further converted into (S)- pregabalin. The disclosers of above said patents, including prior art are incorporated herein by reference.
In both the above processes (R) - 3 -cyano-5 -methyl-hexanoic acid (V) was obtained as an undcsired isomer. The processes disclosed in the above said patents i.e. PCT/IN2010/000440 and co-pending Indian patent Application No. 1235/KOL/2010 dated November 4, 2010, entitled "Novel, cost effective, green and industrial process for synthesis of (S)-pregabalin" are summarized in scheme A.
Figure imgf000003_0001
Scheme A
It is evident from the prior art that whichever process is utilized for resolution to obtain optically pure (S) -3-cyano-5-methyl hexanoic acid (IV), about 50 % of undesired isomer i.e. (R) -3-cyano-5-methyl hexanoic acid (V) will get produced.
Hence, it is imperative that for improvement of overall process efficiency, "atom economy" and cost, the undesired isomer i.e. (R) - 3-cyano-5-methyl-hexanoic acid (V) has to be isomerised through racemization to (RS) - 3-cyano-5-methyl-hexanoic acid (III), which could be resolved through subsequent identical processes described in application entitled "Novel, cost effective, green and industrial process for synthesis of (S)-pregabalin" of the present applicant. In PCT application number PCT/IN2010/000440 dated 28 June 2010, process for racemization of (R) - 3 -cyano-5 -methyl-hexanoic acid ethyl ester (VII) to (RS) - 3-cyano-5- methyl-hexanoic acid ethyl ester (I) was disclosed in presence of catalytic amount of base such as sodium ethoxide and ethanol as a solvent and summarized in scheme B
Figure imgf000004_0001
Scheme B
Racemization of nitrile compounds in presence of base (JACS, 1961, 83, 3678-3687; J. Org. Chem. 1974, 39, 1705-1707) has been reported for benzylic substrates such as (+)-2-methyl- 3 -phenyl propionitrile (VIII), (-)-2-phenylbutyronitrile (IX) and (-) 2,2- diphenylcyclopropylnitrile (X).
Figure imgf000004_0002
(+)-2-methyl-3 -phenyl propionitrile (VIII)
Figure imgf000004_0003
(-)-2-phenylbutyronitrile (IX)
Figure imgf000005_0001
(-) 2,2-diphenylcyclopropylnitrile (X)
"*" denotes carbon bearing optical center.
Although, iri the said publications, racemization of benzylic nitrile substrates has been reported but there is no report for the racemization of substrate containing both carboxyl and cyano functionality i.e. β- cyano esters.
This invention provides a method for racemization of optically active β- cyano ester directly to corresponding racemic β- cyano acid. To the knowledge of the inventors, there is no report available for isomerization of (J?) - 3- cyano-5-methyi-hexanoic acid ethyl ester (VII) to (RS) - 3-cyano-5-methyl-hexanoic acid (III).
Thus, this invention provides a novel, highly cost effective, operation friendly, "green" process for racemization of (R) - 3-cyano-5-methyl-hexanoic acid ethyl ester (VII) to . (RS) - 3-cyano-5-methyl-hexanoic acid (III). Objects of the Invention:
The object of the present invention is to provide a process for recycling of ( ?)-3-cyano-5- methyl-hexanoic acid (V) via converting into corresponding ester i.e. (i?)-3-cyano-5-methyl- hexanoic acid ethyl ester (VII), followed by racemization to obtain (RS) - 3-cyano-5-methyl- hexanoic acid (III), which could be reused for resolution through diastereomeric salt formation with cinchonidine, thereby improving the atom economy and hence further reduce the cost for the synthesis of (S)-pregabalin.
Summary of Invention:
The present invention is directed towards racemization of (ft)-3-cyano-5 -methyl hexanoic acid ethyl ester (VII) to (i?S)-3-cyano-5-methyl hexanoic acid (III) with a base, which is directly utilized for resolution with cinchonidine as mentioned hereinbefore. The invention is summarized below in scheme C.
1) 2 % Ethanol
Dry solvetnt
Figure imgf000006_0001
(VII) (in)
Racemic Mixture (Yield=95%) Sc heme C
The processes for isomerization of (R)-3-cyano-5-methyl hexanoic acid (VII)
(i?)-3-cyano-5 -methyl hexanoic acid ethyl ester (VII) and 2% absolute ethanol was heated at 70 °C for 4 hours in organic solvent such as dimethyl sulfoxide, N,N, dimethylformamide, N- methyl-2-pyrrolidone, 2-methyl tetrahydrofuran, dimethoxy ethane and methyl tert-butyl ether preferably 2-methyl tetrahydrofuran, dimethoxy ethane, methyl fert-butyl ether in presence of a base such as alkali earth metal alkoxides e.g; sodium ethoxide, potassium tert- butoxide, sodium methoxide to obtain (J?S -3-cyano-5-methyl-hexanoic acid (III).
Detailed Description of the Invention:
It is worthwhile to note that, the substrates reported in literature and mentioned above contain only one electron withdrawing group i.e. nitrile, hence, when above said substrates were subjected to racemization in presence of catalytic amount of base, proton which is attached to carbon bearing optically active center i.e. "Ha", which is a to cyano functionality only gets abstracted, which results into isomerization of said nitrile substrates.
In case of substrates like β- cyano ester i.e. 3 -cyano-5 -methyl hexanoic acid ethyl ester (XI), where, two vicinal protons are present as shown in the following structure i.e. "Ha" which is a to carboxyl and "Hb" which is a to cyano functionality, it is difficult to predict which proton will get abstracted in conditions reported in literature.
Figure imgf000007_0001
However, surprisingly it was observed that, when (R) -3 -cyano-5 -methylhexanoic acid ethyl ester (VII) was treated with more than 1 equivalent of base such as sodium ethoxide, in dimethyl sulfoxide and 2 % ethanol, the product was (RS) -3-cyano-5-methylhexanoic acid (III). The product was analyzed by Gas-Liquid chromatography using a Shimadzu GC 2010 system equipped with a chiral column: Chiraledex (20m x 0.25mm x 0.12mm) and FID detector by converting into ester. Retention time for (R) -3-cyano-5-methylhexanoic acid ethyl ester (VII) is 30.10 min and for (S) -3-cyano-5-methylhexanoic acid ethyl ester (II) is 31.09 min. Product was also characterized by NMR and IR having the following spectral data.
NMR spectra (CDC13, 200 MHz): δ 0.95 (d, 3H), 0.96 (d, 3H), 1.36-1.38 (d, 1H), 1.59-1.66 (m, 1H), 1.79-1.85 (m, 1H), 2.59-2.61 (dd, 1H), 2.69-2.75 (dd, 1H), 2.98-3.04 (m, 1H) and IR Spectra (neat): 31 18, 2961, 2935, 2875, 2642, 2244, 1715, 1470, 1174, 11 13 cm'1.
Moreover, it is to be noted that the solvent system reported in the literature such as dimethyl sulfoxide/ 2% ethanol could be replaced with other solvent systems such as 2-methyl tetrahydrofuran/ 2% ethanol, methyl tert-butyl ether/ 2% ethanol, dimethoxy ethane/ 2% ethanol, dimethyl formamide 1 2 % ethanol, and N-Methyl-2-pyrrolidone/ 2 % ethanol without effecting the efficiency of the process and also it is to be noted that water content in the solvent used for reaction is in the range of 0.05 to 0.65 %. Further, it was observed that when (i?)-3-cyano-5-methyl hexanoic acid was treated under similar experimental conditions used for (/?)-3-cyano-5 -methyl hexanoic acid ethyl ester, it did not undergo racemization.
To the best of knowledge of the inventors, there are no reports available for one step racemization of (R) -3-cyano-5-methylhexanoic acid ester (VII) to (RS) -3-cyano-5- methylhexanoic acid (III).
One might rationalize the formation of (RS) -3- cyano-5-methylhexanoic acid (III) from (R) - 3- cyano-5-methylhexanoic acid ester (VII) with the help of following plausible reaction mechanism (Scheme D), which proceeds via a cyclopropanone intermediate.
Figure imgf000009_0001
Scheme D
In literature formation of cyclopropanone through Dieckmann type condensation has been reported as shown in scheme E (Tetrahedron: Asymmetry 13 (2002) 563-567). The present proposed reaction mechanism is akin to Dieckmann condensation.
Figure imgf000009_0002
Scheme E
Thus, racemization of (R) -3-cyano-5-methylhexanoic acid (V) to (RS) -3-cyano-5- methylhexanoic acid (III) comprised of the following steps: compound (V) was converted into corresponding ester i.e. compound (VII) through esterification reaction such as "mixed-anhydride" technique employing ethylchloroformate/ triethylamine with ethanol or through Steglich Esterification or acid catalyzed esterification or esterification by any other conventional methods.
Figure imgf000010_0001
compound (VII) was racemized to obtain compound (III) in presence of alkali metal alkoxides in a mixture of organic solvent e.g. methyl tert-butyl ether doped with 2% ethanol, dimethyl sulfoxide doped with 2% ethanol, dimethylformamide doped with 2% ethanol, dimethoxyethane doped with 2% ethanol, 2-methyl tetrahydrofuran doped with 2% ethanol and N-Methyl-2-pyrrolidone doped with 2% ethanol. Alkali metal alkoxides used such as sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide, lithium methoxide, lithium ethoxide, potassium tert- butoxide preferably sodium methoxide, sodium ethoxide; more preferably sodium ethoxide. Aprotic solvent used such as dimethyl sulfoxide, dimethylformamide, dimethoxyethane, 2-methyl tetrahydrofuran, methyl tert-butyl ether and N-Me'thyl-2- pyrrolidone preferably dimethyl sulfoxide and methyl tert-butyl ether. Protic solvent used such as methanol, ethanol, propanol and butanol, preferably ethanol. Ratio of aprotic solvent to protic solvent varied from 1:99 to 99:1, preferably ratio used was 99: 1. The quantity of base used was 1.25 mol/per mole of substrate. l) 2 % Ethanol
Figure imgf000011_0001
(VII) (in)
Nomenclatures used for the compounds mentioned herein are as understood from the CambridgeSoft® ChemOffice software ChemDraw Ultra version 6.0.1.
Analytical Methods:
The enantiomeric excess (ee) for (S) - 3-cyano-5-methyl-hexanoic acid ethyl ester is determined by Gas-Liquid chromatography using a Shimadzu GC 2010 system equipped with a chiral column (Chiraledex (20m x 0.25mm x 0.12mm)), and FID detector.
The enantiomeric excess (ee) for (S) or (R) - 3-cyano-5-methyl-hexanoic acid is determined via converting into corresponding ester and analyzed on Gas-Liquid chromatography using a Shimadzu GC 2010 system equipped with a chiral column (Chiraledex (20m x 0.25mm x 0.12mm)), and FID detector.
NMR spectra are obtained at 200 and 400 MHz Bruker instruments, with CDC13 as solvent unless otherwise stated. Chemical shifts (3) are given in ppm relative to tetramethylsilane (δ - 0 ppm). IR spectra are recorded on Perkin Elmer Spectrum (Model: Spectrum 100) and absorption bands are given in cm'1. Mass analyses are performed on Shimadzu LCMS 201 OA instrument.
Example 1: Synthesis of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) through Steglich Esterification. A reactor equipped with overheard stirring is charged with 50 mL of dichloromethane 50 mL, ethanol (1.24 g), (R) - 3-cyano-5-methylhexanoic acid (2.1 g) and DCC (5.58 g) at 0 °C. The mixture is stirred for 1 h at 0 °C. Further it is stirred for 12 h at 25 °C. The extent of reaction is monitored on GC for chiral purity for (R) 3-cyano-5-methylhexanoic acid ethyl ester (1.8 g).
FTIR (neat): 2961, 2242, 1738, 1469, 1182, 1023 cm-1.
1H NMR (CDC13, 200 MHz): δ 0.95 (d, 3H), 0.96 (d, 3H), 1.22-1.24 (m, 4H), 1.58 (m, 1H), 1.83 (m, 1H), 2.49 (dd, 1H), 2.65 (dd, 1H), 2.98-3.06 (m, 1H), 4.17 (q, 2H). 13C NMR (CDC13, 50 MHz): 14.1, 21.2, 22.8, 25.8, 26.0, 37.1, 40.7, 61.4, 121.1, 169.7.
MS (EI): C10H17NO2: 183; [M+H20] +: 201.05.
Example 2: Synthesis of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) through mixed-anhydride. A reactor equipped with overheard stirring is charged with 100 mL of dichloromethane, (R) - 3- cyano-5-methylhexanoic acid (26.2 g) and triethyl amine (34.1 g) and resulting reaction mixture was cooled to 0 °C. A solution of ethyl chloroformate (27.5 g) in dichloromethane (l OOmL) was slowly added to the above reaction mixture over a period of 30 min at 0°C and stirred further for 3 h at 25 °C.
After which reaction mixture was cooled to 0°C and ethanol (15.5 g) was added slowly over period of 20-25 min and resultant reaction mixture was further stirred for 1 h at 25 °C. The reaction was quenched by adding 100 ml water and organic layer was separated. Aqueous layer was further extracted with dichloromethane (2*100ml).Combined organic layer was dried over sodium sulfate and solvent was evaporated under reduced pressure to obtain (R) 3-cyano-5- methylhexanoic acid ethyl ester (30.1 g) as yellow oil.
Example 3: Synthesis of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) in presence of sulfuric acid. A reactor equipped with overheard stirring is charged with ethanol (100 mL), (R) - 3-cyano-5- methylhexanoic acid (25.0 g) and concentrated sulfuric acid (0.25 g) and resulting reaction mixture was refluxed for 6 h. After which reaction was cooled to 25 °C, solvent was evaporated under reduced pressure to obtain crude (R) - 3 -cyano-5 -methylhexanoic acid ethyl ester. Crude (R) - 3-cyano-5-methylhexanoic acid ethyl ester was dissolved in di-iso-propyl ether (100 mL) and washed with 10 % aqueous solution of sodium bicarbonate. Organic layer was dried over sodium sulfate and solvent was evaporated under reduced pressure to obtain (R) 3-cyano-5- methylhexanoic acid ethyl ester (30.1 g) as yellow oil.
Example 4: Racemization of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) to (RS) 3- cyano-5-methylhexanoic acid (III) in dimethyl sulfoxide and 2 % ethanol.
A reactor equipped with overheard stirring is charged with (R) 3 -cyano-5 methylhexanoic acid ethyl ester (15.8 g, 0.086 mol), dimethyl sulfoxide (158 ml), ethanol (4 mL ) and sodium ethoxide (7.35 g, 0.10 mol) and resulting reaction mixture was stirred for 4 h at 75 °C. After which reaction mixture was cooled to room temperature neutralized with acetic acid and treated with water (200 mL) in small portions to maintain the temperature below 30 °C. The aqueous phase was extracted with methyl tert-butyl ether (3 x 200 mL), organic phases were combined and dried over sodium sulfate and solvent was evaporated under reduced pressure to give (RS) - 3-cyano-5-methylhexanoic acid (12.5 g 95 % yield and analyzed chiral GC by converting in to ethyl ester) light brown color oil.
FTIR (neat): 31 18, 2961 , 2935, 2875, 2642, 2244, 1715, 1470, 1 174, 11 13 cm"1
1H NMR (CDCb, 200 MHz): δ 0.95 (d, 3H), 0.96 (d, 3H), 1.36-1.38 (d, 1H), 1.59-1.66 (m, 1H), 1.79-1.85 (m, 1H), 2.59-2.61 (dd, 1H), 2.69-2.75 (dd, 1H), 2.98-3.04 (m, 1H).
MS (EI): C8H13N02: 155.19; [M-H] ': 154.00; [M+H] +: 156.15 Example 5: Racemization of (R) 3-cyano-5-methyIhexanoic acid ethyl ester (VII) to (RS) 3- cyano-5-methylhexanoic acid (III) in N-methyl pyrrolidine and 2 % ethanol
A reactor equipped with overheard stirring is charged with (R) 3-cyano-5 methylhexanoic acid ethyl ester (3.0 g), N-methyl pyrrolidine (30 ml), ethanol (0.6 mL ) and sodium ethoxide (1.4 g) and resulting reaction mixture was stirred for 4 h at 75 °C. After which reaction mixture was cooled to room temperature neutralized with acetic acid and treated with water (200 mL) in small portions to maintain the temperature below 40 °C. The aqueous phase was extracted with methyl fert-butyl ether (3 x 100 mL), organic phases were combined and dried over sodium sulfate and solvent was evaporated under reduced pressure to give (RS) - 3-cyano-5-methylhexanoic acid (2.4 g, analyzed chiral GC by converting in to ethyl ester) brown color oil.
Example 6: Racemization of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) to (RS) 3- cyano-5-methyIhexanoic acid (III) in dimethyl formamide and 2 % ethanol
A reactor equipped with overheard stirring is charged with (R) 3-cyano-5 methylhexanoic acid ethyl ester (3.0 g), dimethyl formamide (30 ml), ethanol (0.6 mL ) and sodium ethoxide (1.4 g) and resulting reaction mixture was stirred for 4 h at 75 °C. After which reaction mixture was cooled to room temperature neutralized with acetic acid and treated with water (200 mL) in small portions to maintain the temperature below 40 °C. The aqueous phase was extracted with methyl tert-butyl ether (3 x 100 mL), organic phases were combined and dried over sodium sulfate and solvent was evaporated under reduced pressure to give (RS) - 3-cyano-5-methylhexanoic acid (2.1 g, analyzed chiral GC by converting in to ethyl ester) brown color oil. Example 7: Racemization of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) to (RS) 3- cyano-5-methylhexanoic acid (III) in dimethoxy ethane and 2 % ethanol
A reactor equipped with overheard stirring is charged with (R) 3-cyano-5 methylhexanoic acid ethyl ester (3.0 g), dimethoxy ethane (30 ml), ethanol (0.6 mL ) and sodium ethoxide (1.4 g) and resulting reaction mixture was stirred for 4 h at 75 °C. After which reaction mixture was cooled to room temperature neutralized with acetic acid and treated with water (200 mL) in small portions to maintain the temperature below 40 °C. The aqueous phase was extracted with methyl tert-butyl ether (3 x 100 mL), organic phases were combined and dried over sodium sulfate and solvent was evaporated under reduced pressure to give (RS) - 3-cyano-5-methylhexanoic acid (2.2 g, analyzed chiral GC by converting in to ethyl ester) brown color oil.
Example 8: Racemization of (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) to (RS) 3- cyano-5-methylhexanoic acid (III) in methyl-i'eri'-butyl ether A reactor equipped with overheard stirring is charged with (R) 3-cyano-5 methylhexanoic acid ethyl ester (3.0 g), dimethoxy ethane (30 ml), ethanol (0.6 mL ) and sodium ethoxide (1.4 g) and resulting reaction mixture was stirred for 4 h at 75 °C. After which reaction mixture was cooled to room temperature neutralized with acetic acid and treated with water (200 mL) in small portions to maintain the temperature below 40 °C. Organic layer was separated and aqueous phase was extracted with methyl tert-butyl ether (100 mL), organic phases were combined and dried over sodium sulfate and solvent was evaporated under reduced pressure to give (RS) - 3- cyano-5 -methylhexanoic acid (2.2 g, analyzed chiral GC by converting in to ethyl ester) brown color oil. Example 9: Racemization of enantiomerically enriched (R) 3-cyano-5-methylhexanoic acid ethyl ester (VII) to (RS) 3-cyano-5-methylhexanoic acid (III) in 2-methyl tetrahydrofuran
A reactor equipped with overheard stirring is charged with (R) 3-cyano-5 methylhexanoic acid ethyl ester (3.0 g), 2-methyl tetrahydrofuran (30 ml), ethanol (0.6 mL ) and sodium ethoxide (1.4 g) and resulting reaction mixture was stirred for 4 h at 75 °C. After which reaction mixture was cooled to room temperature neutralized with acetic acid and solvent was evaporated under reduced pressure to obtain residue. Residue was further suspended in water (200 mL) and aqueous phase was extracted with methyl tert-butyl ether (3 x 300 mL), organic phases were combined and dried over sodium sulfate and solvent was evaporated under reduced pressure to give (RS) - 3-cyano-5-methylhexanoic acid (2.0 g, analyzed chiral GC by converting in to ethyl ester) brown color oil.

Claims

A process of racemization of (R) -3-cyano-5-methylhexanoic acid (V) to obtain (SR) -3- cyano-5-methylhexanoic acid (III) comprising
) conversion of (R) -3-cyano-5-methylhexanoic acid (V) into corresponding ester (VII) through esterification reaction such as "mixed-anhydride" technique employing ethylchloroformate/ triethylamine with ethanol or through Steglich esterification or acid catalyzed esterification or esterification by any other conventional methods;
Figure imgf000017_0001
(V) (VII) ii) treatment of compound (VII) with alkali metal alkoxides in a mixture of protic and aprotic polar solvents, wherein aprotic polar solvent is selected from dimethyl sulfoxide, dimethylformamide, dimethoxyethane, 2-methyl tetrahydrofuran, methyl tert-butyl ether and N-Methyl-2-pyrrolidone preferably dimethyl sulfoxide and methyl tert-butyl ether; and protic polar solvent is selected from methanol, ethanol, propanol and butanol.
Figure imgf000017_0002
(VII) (III)
The process as claimed in claim 1, wherein the solvent in step (ii) is selected from methyl tert-butyl ether doped with 2% ethanol, dimethyl sulfoxide doped with 2% ethanol, dimethylformamide doped with 2% ethanol, dimethoxyemane doped with 2% ethanol, 2-methyl tetrahydrofuran doped with 2% ethanol and N-Methyl-2-pyrrolidone doped with 2% ethanol.
3) The process as claimed in claim 1, wherein alkali metal alkoxide in step (ii) is selected from sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide', lithium methoxide, lithium ethoxide, and potassium tert-butoxide.
4) A process for conversion of (R) -3-cyano-5-methylhexanoic acid ethyl ester (VII) to (RS) -3-cyano-5-methylhexanoic acid (III) comprising treatment of compound (VII) with alkali metal alkoxides in a mixture of protic and aprotic polar solvents, wherein aprotic polar solvent is selected from dimethyl sulfoxide, dimethylformamide, dimethoxyethane, 2-methyl tetrahydrofuran, methyl tert-butyl ether and N-Methyl-2-pyrrolidone preferably dimethyl sulfoxide and methyl tert-butyl ether; and protic polar solvent is selected from methanol, ethanol, propanol and butanol.
5) The process as claimed in claim 4, wherein the solvent is selected from methyl tert-butyl ether doped with 2% ethanol, dimethyl sulfoxide doped with 2% ethanol, dimethylformamide doped with 2% ethanol, dimethoxyethane doped with 2% ethanol, 2-methyl tetrahydrofuran doped with 2% ethanol and N-Methyl-2-pyrrolidone doped with 2% ethanol.
6) The process as claimed in claim 1, wherein the alkali metal alkoxide is selected from sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide, lithium methoxide, lithium ethoxide, and potassium tert-butoxide.
PCT/IB2011/000485 2010-11-04 2011-03-07 NOVEL METHOD FOR RACEMIZATION OF OPTICALLY PURE β-CYANO ESTER TO CORRESPONDING RACEMIC β-CYANO ACID WO2012059798A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1234KO2010 2010-11-04
IN1234/KOL/2010 2010-11-04

Publications (2)

Publication Number Publication Date
WO2012059798A2 true WO2012059798A2 (en) 2012-05-10
WO2012059798A3 WO2012059798A3 (en) 2012-07-19

Family

ID=44627251

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2011/000485 WO2012059798A2 (en) 2010-11-04 2011-03-07 NOVEL METHOD FOR RACEMIZATION OF OPTICALLY PURE β-CYANO ESTER TO CORRESPONDING RACEMIC β-CYANO ACID

Country Status (1)

Country Link
WO (1) WO2012059798A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1912931A2 (en) * 2006-05-31 2008-04-23 Teva Pharmaceutical Industries Ltd. Preparation of (s)-pregabalin-nitrile

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
J.ORG. CHEM., vol. 39, 1974, pages 1705 - 1707
JACS, vol. 83, 1961, pages 3678 - 3687
TETRAHEDRON: ASYMMETRY, vol. 13, 2002, pages 563 - 567

Also Published As

Publication number Publication date
WO2012059798A3 (en) 2012-07-19

Similar Documents

Publication Publication Date Title
CN112521282A (en) Bepaidic acid intermediate and synthesis method thereof
US10081613B2 (en) 2-(alkoxy or aryloxy carbonyl)-4-methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hex-2-enoic acid compounds, its preparation and use
Cui et al. Enantioselective catalytic epoxidation of α, β-enones promoted by fluorous α, α-diaryl-L-prolinols
Ooi et al. Asymmetric Synthesis of α‐Acyl‐γ‐butyrolactones Possessing All‐Carbon Quaternary Stereocenters by Phase‐Transfer‐Catalyzed Alkylation
Zhao et al. FeCl3· 6H2O-catalyzed synthesis of β-ketothioesters from chain α-oxo ketene dithioactals
Enoki et al. Preparation of optically pure flurbiprofen via an integrated chemo-enzymatic synthesis pathway
WO2012059798A2 (en) NOVEL METHOD FOR RACEMIZATION OF OPTICALLY PURE β-CYANO ESTER TO CORRESPONDING RACEMIC β-CYANO ACID
Chen et al. Synthetic studies on (+)-biotin, part 15: A chiral squaramide-mediated enantioselective alcoholysis approach toward the total synthesis of (+)-biotin
WO2011141923A2 (en) Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
CA2582840A1 (en) Processes for producing (4e)-5-chloro-2-isopropyl-4-pentenoate and optically active form thereof
Gonsalves et al. Approach to a better understanding and modelling of β-pyrrolidinoalcohol ligands for enantioselective alkylation
Li et al. A New Approach to the Asymmetric Reaction of the Chiron 5‐L‐Menthyloxy‐2 (5H)‐furanones with Horner‐Emmons Reagent
KR100763770B1 (en) Process for preparing chiral intermediates useful in synthesis of atorvastatin
AU776101B2 (en) Production method of 2-cyclohexyl-2-hydroxy-2-phenylacetic acid intermediate therefor and production method thereof
Bredikhina et al. Synthesis of enantiomerically pure 3-aryloxy-2-hydroxypropanoic acids, intermediate products in the synthesis of cis-4-Aminochroman-3-ols
US8940920B2 (en) Method for preparation of (2-hydroxy-3-oxo-cyclopent-1-enyl)-acetic acid esters
JP2000063321A (en) Production of long-chain beta-hydroxycarboxylic acid of high optical purity
Alberch et al. Synthesis of compounds containing α-aryl quaternary carbon centers
TWI530485B (en) Method for producing 3,4-dihydroisoquinoline derivatives
JP5344287B2 (en) Process for producing α-difluorohalomethylcarbonyl compound
Sukanya et al. Lithium hydroxide catalyzed Michael addition–An easy handling and non-toxic protocol
Makama Samarium (II) Iodide Mediated Synthesis of 3, 5-dimethyl-hexahydrocyclopenta [b] furnan-2-one
CN1995006A (en) (2-alkoxy-4-oxo)-penta-2-enoate compound preparation method
Fang et al. Enantioselective Reformatsky Reaction between Cinnamaldehyde and Diflurinated Organozinc Reagent: Synthesis of Chiral γ, γ-difluoro-β-hydroxy Esters as Precursors of Statin Analogues
Lach et al. Unprecedented syntheses of 1, 5-difluoropentan-3-amine and 4-fluoro-2-(2-fluoroethyl) butan-1-amine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11726487

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11726487

Country of ref document: EP

Kind code of ref document: A2